You’ve probably seen the headlines. Maybe a friend mentioned one of these at dinner. Or you’ve spent way too many late nights scrolling through Reddit threads trying to figure out which weight loss injection is “the best.”
Here’s the thing: both semaglutide and tirzepatide work. Really well, actually. But that doesn’t make choosing between them any easier when you’re the one pulling out your wallet and rolling up your sleeve.
Let me walk you through what we actually know, what we don’t, and how to think about this decision practically.
What are these medications, anyway?
Semaglutide is the active ingredient in Ozempic (approved for type 2 diabetes) and Wegovy (approved specifically for weight loss). It’s a GLP-1 receptor agonist, which means it mimics a hormone your gut naturally produces after eating.
Tirzepatide is the active ingredient in Mounjaro (diabetes) and Zepbound (weight loss). It does what semaglutide does, but adds a second mechanism. It also activates GIP receptors. Think of it as a dual approach rather than a single one.
Both medications work by slowing stomach emptying, reducing appetite, and affecting how your brain perceives hunger and fullness. You take them as weekly injections, and both require a gradual dose increase over several months.
Now, here’s where it gets interesting.
The weight loss numbers: what the studies show
People love comparing percentages, so let’s get into it.
In the STEP trials for semaglutide, participants lost an average of about 15% of their body weight over 68 weeks at the highest dose. For someone starting at 220 pounds, that’s roughly 33 pounds.
The SURMOUNT trials for tirzepatide showed higher numbers. At the maximum dose, average weight loss hit around 21% of body weight. Same starting weight? That’s about 46 pounds.
The honest answer is that tirzepatide appears more effective on paper. The head-to-head data we have (including the SURPASS trials comparing the two in diabetes patients) generally favors tirzepatide for both weight loss and blood sugar control.
But here’s what those percentages don’t tell you.
These are averages across large groups. Some people lose significantly more. Others lose less. A small percentage don’t respond much at all. Your individual response depends on factors researchers are still trying to understand, including genetics, baseline metabolic health, diet, activity level, and probably things we haven’t identified yet.
What we don’t know yet is how to predict who will respond better to which medication. There’s no blood test or quiz that tells you “semaglutide is your match.” You might be someone who loses 20% on semaglutide, or someone who needs tirzepatide to see meaningful results. We just can’t predict that in advance.
Side effects: the stuff no one wants to talk about (but should)
Both medications share a similar side effect profile because they work on similar pathways. The most common complaints are gastrointestinal: nausea, vomiting, diarrhea, constipation.
These effects tend to be worst during dose escalation. Most people find they improve significantly after the first couple months as their body adjusts. Starting low and increasing slowly helps.
Some people tolerate one medication better than the other, but there’s no reliable way to predict this ahead of time.
More serious but rare concerns include:
Pancreatitis has been reported with both medications. If you have a history of pancreatitis, these might not be appropriate for you.
Gallbladder issues, including gallstones, occur more frequently with rapid weight loss in general. Both medications can contribute to this.
There’s a boxed warning about thyroid C-cell tumors based on rodent studies. This hasn’t been confirmed in humans, but if you have a personal or family history of medullary thyroid cancer or MEN 2 syndrome, these medications are off the table.
The honest answer about side effects is that most people tolerate these medications reasonably well once they get past the initial adjustment period. But “most people” might not include you. Some folks struggle with persistent nausea that never fully resolves. Others deal with significant constipation or fatigue.
Talk to someone who’s actually taken these medications for six months or more. The first few weeks are rough for many people, but the longer-term experience varies widely.
The cost reality check
Let’s talk money, because this is often the deciding factor.
Without insurance, both medications cost roughly $900 to $1,200+ per month at retail pharmacies. Yes, per month.
Insurance coverage is inconsistent and often frustrating. Many plans cover these medications for diabetes but exclude weight loss indications. Some require prior authorizations, step therapy (trying cheaper medications first), or documented obesity-related health conditions.
Manufacturer savings programs exist but usually only work if you have commercial insurance. Medicare Part D explicitly doesn’t cover anti-obesity medications, which affects millions of people.
Compounded versions of semaglutide have become popular as a lower-cost alternative. These are made by compounding pharmacies and aren’t FDA-approved brand-name products. Quality varies. Some people have good experiences while others receive inconsistent products. This is a whole separate conversation worth having with a healthcare provider who understands the landscape.
The practical reality is that cost often makes this decision for people. If your insurance covers semaglutide but not tirzepatide (or vice versa), that’s probably your answer, at least to start.
So which one should you try first?
Here’s how I’d think about it.
Consider starting with semaglutide if:
Your insurance covers it better than tirzepatide. It’s been on the market longer, so we have more long-term safety data (though tirzepatide’s data is catching up). You want to start with the option that has a slightly longer track record. It’s more likely to be available. Tirzepatide shortages have been more common.
Consider starting with tirzepatide if:
Your insurance covers it equally well or you’re paying out of pocket and want to maximize your chances of significant weight loss. You’ve already tried semaglutide without adequate results. The higher average efficacy matters to you and you’re willing to accept a slightly shorter safety track record.
What actually matters more than which one you pick:
Can you afford to stay on it long-term? These medications work while you take them. Most people regain weight after stopping. This isn’t a moral failing. It’s biology.
Do you have a healthcare provider who will monitor you appropriately? Regular check-ins matter, especially in the first year.
Are you making sustainable changes alongside the medication? Neither drug is magic. They make appetite regulation easier, but they work best when combined with eating patterns and movement you can actually maintain.
The question nobody wants to ask
What happens if the first one doesn’t work well for you?
Switching is an option. Some people who don’t respond adequately to semaglutide do better on tirzepatide. The reverse is less commonly reported but possible.
The honest answer is that we don’t have great data on switching between these medications. Most clinical trials studied them in isolation. Real-world experience suggests switching can be worthwhile, but it means starting the dose titration process over again.
If cost weren’t a factor and you had complete freedom to choose, tirzepatide’s efficacy data would make it the logical first choice for most people. But cost is almost always a factor. And semaglutide works extremely well for many people.
What I’d actually tell a friend
Start with whichever one you can realistically afford and access. Give it at least 4 to 6 months at therapeutic doses before deciding it isn’t working. Track your progress beyond the scale, including energy, hunger patterns, how your clothes fit, and lab values if you have access to them.
If you’re not seeing meaningful results after giving it a fair shot, switching to the other medication is reasonable. And if neither works well for you, that’s not a personal failure. It’s useful information about your biology.
These medications represent a real shift in how we can address obesity. But they’re tools, not miracles. The right one for you is the one you can actually take consistently, afford long-term, and tolerate without your quality of life tanking.
That’s the unsexy but honest answer.